Article
Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
European journal of pharmacology - 15 Jan 2015
Qiu Li-Na, Sun Yan, Wang Lin, Han Rui-Fa, Xia Xiao-Shuang, Liu Jie, Li Xin
Abstract excerpt
CYP2C19 genetic polymorphisms influence clopidogrel response and clinical outcomes of cardiovascular disease. However, data on their relationship in stroke patients are scarce. We aimed to investigate the influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. A total of 211 patients were enrolled. All patients were given clopidogrel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
